Enabling the development of highly efficient and safe #AntibodyDrugConjugates (ADCs) through our proprietary linker technology.
Au ZH, Switzerland
Joined August 2021
- Tweets204
- Following98
- Followers99
- Likes22
Enabling the development of highly efficient and safe #AntibodyDrugConjugates (ADCs) through our proprietary linker technology.
